Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 912,262 |
|
|||||
| News | - | ||||||
| Day High | 7.955 | Low High |
|||||
| Day Low | 7.68 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| RAPT Therapeutics Inc | RAPT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.08 | -1.02% | 7.80 | 16:23:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.84 | 7.68 | 7.955 | 7.70 | 7.88 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,349 | 912,262 | US$ 7.82 | US$ 7,129,978 | - | 6.86 - 27.35 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:51:02 | 48 | US$ 7.75 | USD |
RAPT Therapeutics (RAPT) Options Flow Summary
RAPT Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 267.94M | 34.80M | - | 0 | -116.8M | -3.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
RAPT Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RAPT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.98 | 8.4354 | 7.52 | 7.92 | 461,129 | -0.18 | -2.26% |
| 1 Month | 8.30 | 9.6536 | 7.52 | 8.39 | 766,532 | -0.50 | -6.02% |
| 3 Months | 25.09 | 27.35 | 6.86 | 9.39 | 1,434,995 | -17.29 | -68.91% |
| 6 Months | 11.63 | 27.35 | 6.86 | 12.01 | 900,187 | -3.83 | -32.93% |
| 1 Year | 18.16 | 27.35 | 6.86 | 13.72 | 604,123 | -10.36 | -57.05% |
| 3 Years | 22.09 | 43.26 | 6.86 | 21.66 | 479,049 | -14.29 | -64.69% |
| 5 Years | 12.25 | 51.2095 | 6.86 | 22.02 | 379,805 | -4.45 | -36.33% |
RAPT Therapeutics Description
| RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. |
